Tag Archives: from

Johnson & Johnson’s COVID-19 vaccine wins renewed backing from U.S. experts after probe into rare blood clots

After officials halted Johnson & Johnson’s COVID-19 vaccine rollout in its tracks last week, U.S. vaccine advisers agreed on Friday that vaccinations should resume. Going forward, the shot will carry a warning about rare and severe blood clots, they said. Of the nearly 8 million doses administered, officials identified 15 cases of thrombosis with thrombocytopenia (TTS), CDC vaccine advisers said Friday. Three vaccine recipients who developed TTS have died. All… Read More »

Virtual Health Tech Enables the Continuum of Health from Hospital to Home

In the COVID-19 pandemic, as peoples’ daily lives shifted closer and closer to home, and for some weeks and months home-all-the-time, health care, too, moved beyond brick-and-mortar hospitals and doctors’ offices. The public health crisis accelerated “what’s next” for health care delivery, detailed in A New Era of Virtual Health, a report published by TripleTree. TripleTree… Read More »